Benzgalantamine, sold under the brand name Zunveyl, is a medication used for the treatment of mild to moderate dementia of the Alzheimer's type. It is a cholinesterase inhibitor. Benzgalantamine is a prodrug of galantamine.
Medical uses
Benzgalantamine is indicated for the treatment of mild to moderate dementia of the Alzheimer's type in adults. == Side effects ==
Side effects
The most common side effects include nausea, vomiting, diarrhea, dizziness, headache, and decreased appetite. == Society and culture ==
Society and culture
Legal status Benzgalantamine was approved for medical use in the United States in July 2024. == References ==